Exploitation of Langerhans cells for in vivo DNA vaccine delivery into the lymph nodes von Tőke, E R, Lőrincz, O, Csiszovszki, Z, Somogyi, E, Felföldi, G, Molnár, L, Szipőcs, R, Kolonics, A, Malissen, B, Lori, F, Trocio, J, Bakare, N, Horkay, F, Romani, N, Tripp, C H, Stoitzner, P, Lisziewicz, J

Volltext

149P Evaluation of HLA genotype as predictive biomarker for immunological and clinical responses upon vaccination with PolyPEPI1018 cancer vaccine against colorectal cancer von Hubbard, J., Molnar, L., Toth, J., Lorincz, O., Csiszovszki, Z., Somogyi, E., Toke, E.R.

Volltext

640P A phase II, multicenter, open-label study of PolyPEPI1018 in combination with atezolizumab in participants with relapsed or refractory microsatellite-stable metastatic colorec... von Hubbard, J., Ahn, D., Jones, J.C., Jin, Z., Zhu, M., Xie, H., Novo, E., Graham, R., Wittenberger, K., Kremlitzka, M., Csiszovszki, Z., Somogyi, E., Lorincz, O., Molnar, L., Toth, J., Youssoufian, H., Toke, E.R.

Volltext

Computational model to predict response rate of clinical trials von Lorincz, O., Toth, J., Megyesi, M., Pántya, K., Miklos, I., Somogyi, E., Csiszovszki, Z., Pales, P., Molnar, L., Tőke, E.R.

Volltext

1423P - Inferring the correlation between incidence rates of melanoma and the average tumour-specific epitope binding ability of HLA class I molecules in different populations von Miklos, I., Molnar, L., Toth, J., Lorincz, O., Csiszovszki, Z., Pales, P., Pántya, K., Megyesi, M., Somogyi, E., Tőke, E.R.

Volltext

Inferring the correlation between incidence rates of melanoma and the average tumour-specific epitope binding ability of HLA class I molecules in different populations von Miklos, I., Molnar, L., Toth, J., Lorincz, O., Csiszovszki, Z., Pales, P., Pántya, K., Megyesi, M., Somogyi, E., Tőke, E.R.

Volltext

1935P - Computational model to predict response rate of clinical trials von Lorincz, O., Toth, J., Megyesi, M., Pántya, K., Miklos, I., Somogyi, E., Csiszovszki, Z., Pales, P., Molnar, L., Tőke, E.R.

Volltext

1423PInferring the correlation between incidence rates of melanoma and the average tumour-specific epitope binding ability of HLA class I molecules in different populations von Miklos, I, Molnar, L, Toth, J, Lorincz, O, Csiszovszki, Z, Pales, P, Pántya, K, Megyesi, M, Somogyi, E, Tőke, E R

Volltext

1181PDPersonal antigen selection calculator (PASCal) for the design of personal cancer vaccines von Somogyi, E, Csiszovszki, Z, Lorincz, O, Toth, J, Molnar, L, Schönharting, W, Urban, S, Röhnisch, T, Pántya, K, Pales, P, Megyesi, M, Tőke, E R

Volltext

Personal antigen selection calculator (PASCal) for the design of personal cancer vaccines von Somogyi, E., Csiszovszki, Z., Lorincz, O., Toth, J., Molnar, L., Schönharting, W., Urban, S., Röhnisch, T., Pántya, K., Pales, P., Megyesi, M., Tőke, E.R.

Volltext

1935PComputational model to predict response rate of clinical trials von Lorincz, O, Toth, J, Megyesi, M, Pántya, K, Miklos, I, Somogyi, E, Csiszovszki, Z, Pales, P, Molnar, L, Tőke, E R

Volltext

1181PD - Personal antigen selection calculator (PASCal) for the design of personal cancer vaccines von Somogyi, E., Csiszovszki, Z., Lorincz, O., Toth, J., Molnar, L., Schönharting, W., Urban, S., Röhnisch, T., Pántya, K., Pales, P., Megyesi, M., Tőke, E.R.

Volltext

606PEvaluation of safety, immunogenicity and preliminary efficacy of PolyPEPI1018 vaccine in subjects with metastatic colorectal cancer (mCRC) with a predictive biomarker von Hubbard, J, Cremolini, C, Graham, R P, Moretto, R, Mitchell, J, Wessling, J, Tőke, E R, Csiszovszki, Z, Lorincz, O, Molnar, L, Somogyi, E, Megyesi, M, Pántya, K, Toth, J, Pales, P, Miklos, I, Falcone, A

Volltext

Evaluation of safety, immunogenicity and preliminary efficacy of PolyPEPI1018 vaccine in subjects with metastatic colorectal cancer (mCRC) with a predictive biomarker von Hubbard, J., Cremolini, C., Graham, R.P., Moretto, R., Mitchell, J., Wessling, J., Tőke, E.R., Csiszovszki, Z., Lorincz, O., Molnar, L., Somogyi, E., Megyesi, M., Pántya, K., Toth, J., Pales, P., Miklos, I., Falcone, A.

Volltext

606P - Evaluation of safety, immunogenicity and preliminary efficacy of PolyPEPI1018 vaccine in subjects with metastatic colorectal cancer (mCRC) with a predictive biomarker von Hubbard, J., Cremolini, C., Graham, R.P., Moretto, R., Mitchell, J., Wessling, J., Tőke, E.R., Csiszovszki, Z., Lorincz, O., Molnar, L., Somogyi, E., Megyesi, M., Pántya, K., Toth, J., Pales, P., Miklos, I., Falcone, A.

Volltext

PHP163 - The Normal Reimbursement Procedure Of The Pharmaceutical Submissions Between 2013 And 2015 In Hungary - Needs And Results von Csordás, A, Lőrincz, O, Éder, B

Volltext

The Normal Reimbursement Procedure Of The Pharmaceutical Submissions Between 2013 And 2015 In Hungary - Needs And Results von Csordás, A, Lőrincz, O, Éder, B

Volltext

An Interactive Analysis and Exploration Tool for Epigenomic Data von Younesy, H., Nielsen, C.B., Möller, T., Alder, O., Cullum, R., Lorincz, M.C., Karimi, M.M., Jones, S.J.M.

Volltext

Business transactions and ownership ties between firms von Lőrincz, László, Juhász, Sándor, O. Szabó, Rebeka

Volltext

Patient Decisions Regarding Rescheduling Colonoscopies Postponed Due to the COVID-19 Pandemic von Linz, Marguerite O., Lorincz-Comi, Noah, Kuwatch, Abigail A., Cooper, Gregory S.

Volltext